TLT — Theralase Technologies Balance Sheet
0.000.00%
Last trade - 00:00
- CA$38.84m
- CA$38.91m
- CA$1.07m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 12.5 | 7.88 | 3.71 | 1.65 | 0.318 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.824 | 0.485 | 0.283 | 0.296 | 0.325 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 14.2 | 8.92 | 5 | 2.5 | 1.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.15 | 1.04 | 0.866 | 1.11 | 0.858 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 15.5 | 10 | 5.94 | 4.16 | 3.28 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.52 | 0.821 | 0.875 | 0.681 | 1.08 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.61 | 0.857 | 0.875 | 1.07 | 1.37 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 13.9 | 9.16 | 5.07 | 3.09 | 1.91 |
Total Liabilities & Shareholders' Equity | 15.5 | 10 | 5.94 | 4.16 | 3.28 |
Total Common Shares Outstanding |